Počet záznamov: 1
HMG CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase inhibitors
SYS c006383 LBL ^^^^^nam^^22^^^^^^^^450^ 005 20001205103001.0 100 $a 19940325d1990 u y0sloc0103 ba 101 0-
$a eng 102 $a US 105 $a y z 100yy 200 1-
$a HMG CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase inhibitors $e <a> five year clinical perspective $f S. M. Grundy (ed.) $e symposium, November 12, 1989, New Orleans, Louisiana 210 $a Washington $c Reed $d 1990 215 $a 55 s. 225 2-
$a American Journal of Cardiology $v [Supl.] 410 -1
$1 001 sllk_un_cat*s003258 $1 500 10 $a American Journal of Cardiology 606 $a lovastatín $x farmakológia $2 mesh $3 sllk_un_auth*d008148 606 $3 sllk_un_auth*d003226 $a kongresy ako téma $y Spojené štáty americké $y Louisiana $2 mesh 606 $a hydroxymetylglutaryl-CoA-reduktázy $x antagonisty a inhibítory $x farmakológia $2 mesh $3 sllk_un_auth*d006903 606 $a hypercholesterolémia $x farmakoterapia $2 mesh $3 sllk_un_auth*d006937 606 $a hypercholesterolémia $2 mesh $3 sllk_un_auth*d006937 675 $a 616.153.915(547.922):615.272.4.03(061.3) $v 1. stred. $z slo 702 -1
$a Grundy $b S. M. $g Scott M. $3 sllk_un_auth*p0015596 $4 340 801 -0
$a SK $b BA006 $c 19981223 $g AACR2
Počet záznamov: 1